Proteasome Inhibition Leads to Significant Reduction of Bcr-Abl Expression and Subsequent Induction of Apoptosis in K562 Human Chronic Myelogenous Leukemia Cells
- 4 January 2025
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 289 (2) , 781-790
- https://doi.org/10.1016/s0022-3565(24)38201-1
Abstract
No abstract availableThis publication has 66 references indexed in Scilit:
- A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometryPublished by Elsevier ,2002
- Ubiquitin, proteasomes, and the regulation of intracellular protein degradationPublished by Elsevier ,2002
- Brefeldin A Is a Potent Inducer of Apoptosis in Human Cancer Cells Independently of p53Experimental Cell Research, 1996
- Involvement of the proteasome in the programmed cell death of NGF-deprived sympathetic neurons.The EMBO Journal, 1996
- The effect of bcr-abl antisense oligonucleotide on DNA synthesis and apoptosis in K562 chronic myeloid leukemia cellsLeukemia Research, 1996
- Lactacystin, a Specific Inhibitor of the Proteasome, Induces Apoptosis in Human Monoblast U937 CellsBiochemical and Biophysical Research Communications, 1995
- Protease activation during apoptosis: Death by a thousand cuts?Cell, 1995
- bcr-abl, the hallmark of chronic myeloid leukaemia in man, induces multiple haemopoietic neoplasms in mice.The EMBO Journal, 1990
- An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activityCell, 1984